IVD

How a Tiny Device Is Making a Big Difference for Pediatric Transplant Patients

An initiative at Nottingham University Hospital in Nottingham, England is making it easier for pediatric transplant patients and their caregivers to collect blood samples at home for therapeutic drug monitoring.

New Field Test Discerns Between Ebola and Lookalike Fevers

The portable device could prove to be invaluable during an Ebola outbreak.

Investigators on the Path to Alzheimer’s Detection Test

A team from Brigham and Women’s Hospital are developing a test that can detect tau protein, a calling card for Alzheimer’s disease.

GRAIL’s SUMMIT Will Help Define its Liquid Biopsy Path

The Menlo Park, CA-based company’s 50,000-patient trial will launch in 2019 and could be one of the most significant events of the year for the liquid biopsy market.

How a New Blood Volume Analyzer Could Save Lives From Acute Heart Failure

Daxor’s new technology designed to measure blood volume has the potential to reduce patient readmission rates and improve outcomes for patients suffering from acute heart failure.

Diagnostics Are Helping Counter Antimicrobial Resistance, But More Work Is Needed

Doctors need more tools to quickly determine whether an antibiotic is truly needed, an expert tells MD+DI.

Oxford Startup Wants to Revolutionize Sensors

A startup spawned from Oxford University is trying to commercialize components of a quantum computing technology that could ultimately improve the downstream end of existing diagnostic devices.

New Blood Test Makes the Autism Picture a Bit Clearer

The Madison, WI-based company said its test can identify metabolic subtypes associated with the Autism Spectrum and can be used to screen children as young as 18 months.

New York State Initiative Hopes to Stop the Spread of Super Bugs

Diagnostics manufacturer OpGen is partnering with ILUM and the NY State Department of Health to detect, track, and manage antimicrobial-resistant infections at healthcare institutions statewide.

What Will Be Your Next Move in the In Vitro Diagnostic Space?

A panel of IVD experts will discuss the latest in vitro diagnostic trends at the BIOMEDevice San Jose conference in December.

Bringing Precision Diagnostics Home

New technologies in RNA analysis tests benefit autoimmune disease sufferers.

Abbott-Alere One Year Later: Was It Worth All the Fuss?

It's been a full year since Abbott closed its $5.3 billion acquisition of Alere, a deal that almost didn't happen.

MeMed Looks to Distinguish Between Bacterial and Viral Infections

The Haifa, Israel-based company has raised more than $70 million in a funding round.

Image of the EssenceChip courtesy of Aromyx Corp.

Could a New Biosensor Be Able to Smell Cancer?

Aromyx Corp. announces its groundbreaking biosensor technology based on the human sense of smell and taste. The company says the new technology has the potential to be used as a diagnostic tool to detect early stage cancer and disease.